NIKKEI 225
39,103.22 +486.12 (+1.26%) HANG SENG
18,868.71 -326.89 (-1.70%) CRUDE OIL
76.60 -0.97 (-1.25%) GOLD FUTURES
2,335.20 -57.70 (-2.41%) DOW
39,093.43 -577.61 (-1.46%) Bitcoin GBP
52,965.89 -1,941.94 (-3.54%)
BMY Sep 2024 42.000 call
- Simply Wall St.
Does Bristol-Myers Squibb (NYSE:BMY) Have A Healthy Balance Sheet?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
- Business Wire
Bristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology Annual Meeting
PRINCETON, N.J., May 23, 2024--Bristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology Annual Meeting
- Benzinga
Hawaii Court Rules Against Bristol Myers, Sanofi In Blood Clot Drug Case, Increases Liability To $916M
A judge in Hawaii has reportedly ordered Bristol Myers Squibb & Co (NYSE:BMY) and Sanofi SA (NASDAQ:SNY) to pay the state over $916 million for failing to warn non-white patients about health risks associated with their blood thinner Plavix. This decision marks an increase from an earlier $834 million judgment. Judge James Ashford of Hawaii’s First Circuit Court’s ruling follows a non-jury trial held last fall and represents the second trial in this case. The state’s Supreme Court had previously
